Opioid agonist/antagonist effect of naloxone in modulating rabbit jejunum contractility in vitro

Journal of Physiology and Pharmacology

Volumn 57, Issue 3, 2006, Pages 439-449

  Cosola, C ^a   Albrizio, Maria ^a   Guaricci, A C ^a   De Salvia, M A ^a   Zarrilli, A ^a   Sciorsci, R L ^a   Minoia, R ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Beta endorphin; Mu opioid receptor; Naloxone; Opioids; Rabbit jejunum

Indexed keywords

BETA ENDORPHIN; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; OPIATE AGONIST; OPIATE ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; IN VITRO STUDY; INTESTINE MOTILITY; JEJUNUM MUCOSA; NONHUMAN; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BETA-ENDORPHIN; BLOTTING, WESTERN; GASTROINTESTINAL MOTILITY; JEJUNUM; MUSCLE CONTRACTION; NALOXONE; NARCOTIC ANTAGONISTS; RABBITS; RECEPTORS, OPIOID, MU;

EID: 33749606634     PISSN: 08675910     EISSN: 08675910     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Vaccarino AL, Abba JK. Endogenous opiates: 2000. Peptides 2001; 22: 2257-2328.
2. Minami M, Satoh M. Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci Res 1995; 23: 121-145.
3. Witter G, Hope P, Pyle D. Tissue distribution of opioid receptor gene expression in the rat. Biochem Biophys Res Com 1996; 218: 977-981.
4. Dell'Aquila ME, Casavola V, Reshkin SJ, et al. Effects of b-Endorphin and Naloxone on in Vitro Maturation of Bovine Oocytes. Mol Reprod Dev 2002; 63: 210-222.
5. Albrizio M, Guaricci AC, Maritato F, et al. Expression and subcellular localization of the muopioid receptor in equine spermatozoa. Evidence for its functional role. Reproduction 2005; 129: 39-49.
6. Fickel J, Bagnol D, Watson SJ, Akil H. Opioid receptor expression in the rat gastrointestinal tract: a quantitative study with comparison to the brain. Brain Res Mol Brain Res 1997; 46:1-8.
7. Valeri P, Morrone LA, Romanelli L. Manifestations of acute opiate withdrawal contracture in rabbit jejunum after mu-, kappa- and delta-receptor agonist exposure. Br J Pharmacol 1992; 106: 39-44.
8. Capasso A. Further studies on the involvement of the arachidonic acid cascade in the acute dependence produced by m, κ and δ opioid agonists in isolated tissues. Neuropharm 1999; 38: 871-877.
9. Corazziari E. Role of opioid ligands in the irritable bowel syndrome. Can J Gastroenterol 1999; 13 Suppl A: 71A-75A.
10. Dinari G, Ashkenazi S, Marcus H, Rosenbach Y, Zahavi I. The effect of opiates on the intestinal immune response to cholera toxin in mice. Digestion 1989; 44: 14-19.
11. Gustein HB, Akil H. Opioids analgesics. In The pharmacological basis of therapeutics JG Hardman, LE Limbird (eds). USA, McGraw-Hill, 2001, pp. 569-619.
12. Yoshida S, Tajiri T, Yoshizumi T. Administration of opiate receptor antagonist inhibits mucosal atrophy of the gut in fasting rats. J Surg Res 2000; 93: 177-181.
13. Pol O, Ferrer I, Puig MM. Diarrhea associated with intestinal inflammation increases the potency of μ and δ opioids on the inhibition of gastrointestinal transit in mice. J Pharmacol Exp Ther 1994; 270: 386-391.
14. Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 2003; 63: 649-671.
15. Hirst GD. A calcium window to the gut. Nature 1999; 399: 16-17.
16. 2+ channels in GH3 cells by cloned mu- and delta-opioid receptors. Mol Pharmacol 1996; 50: 947-956.
17. 2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioid-dependent rats. Brain Res 1996; 722: 212-216.
18. + exchange by activating protein kinase C via the mobilization of intracellular calcium. Exp Nephrol 2001; 9: 341-348.
19. Nakanishi S, Inoue A, Kita T, et al. Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor. Nature 1979; 278:423-427.
20. Xue JC, Chen C, Zhu J, et al. The third extracellular loop of the mu opioid receptor is important for agonist selectivity. J Biol Chem 1995; 270: 12977-12979.
21. Liu-Chen LY, Chen C, Phillips CA. Beta-[3H]funaltrexamine-labelled mu opioid receptors: species variations in molecular mass and glycosylation by complex-type N-linked oligosaccharides. Mol Pharmacol 1993; 44: 749-756.
22. Mousa SA, Zhang Q, Sitte N, Ji RR, Stein C. Beta endorphin-containing memory-cells and mu opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol 2001; 115: 71-78.
23. Liu BH, Mo P, Zhang SB. Effects of mu and kappa opioid receptor agonists and antagonists on contraction of isolated colon strips of rats with cathartic colon World J Gastroenterol 2004; 10: 1672-1674.
24. Kaufman PN, Krevsky B, Malmud LS et al. Role of opiate receptor in the regulation of colonic transit Gastroenterology 1988; 94: 1351-1356.
25. Liu M, Wittbrodt E. Low-dose oral naloxone reverses opioid-induced constipation and analgesia. J Pain Symptom Manage 2002; 23: 48-53.
26. 2+ in the contractility of rabbit small intestine in vitro J Physiol Pharmacol 2004; 55: 639-650.
27. Sciorsci RL, Bianchi P, Minoia P. High Levels of Endorphin and Related Pathologies of veterinary Concern. A Rewiev. Immunopharmacol immunotoxicol 2000; 22: 575-626.